- Active not recruitingPHASE3
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
This study looks at a new drug, vimseltinib, for a condition called Tenosynovial Giant Cell Tumor (TGCT) when surgery isn't possible. It compares vimseltinib to a dummy drug for 24 weeks, then everyone gets the real drug. It aims to see how well it shrinks tumors.
For: Tenosynovial Giant Cell Tumor · Pigmented Villonodular Synovitis · Giant Cell Tumor of Tendon SheathUnited States · Australia · Canada - Active not recruitingPHASE1, PHASE2
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
This study is testing a new drug, vimseltinib, for advanced cancers and a specific joint condition called Tenosynovial Giant Cell Tumor (TGCT). It aims to find the right dose and see how well it works.
For: Advanced Malignant Neoplasm · Pigmented Villonodular Synovitis · Giant Cell Tumor of Tendon SheathUnited States · Australia · Canada